Neither vitamin D3 nor omega-3 fatty acids affected eGFR at 5 years in a sub-study of the VITAL trial. Doctors need to make it clear to patients that there are no benefits of these supplements, says author.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.